{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-061330","form_type":"8-K","ticker":null,"cik":"0000811240","company_name":"BIOLASE, INC","filed_at":"2024-05-17T23:59:59+00:00","discovered_at":"2026-05-14T18:03:22.038405+00:00","generated_at":"2026-06-01T17:54:09.518114+00:00","sec_items":["3.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.9,"calibrated_materiality_score":0.9,"confidence":"high","headline":"BIOLASE receives Nasdaq delisting notice for negative equity of -$1.93M","bullets":["Nasdaq notified BIOLASE on May 14, 2024 that stockholders' equity of ($1.93M) fails minimum $2.5M requirement.","This is an additional basis for delisting and will be considered by the Nasdaq Hearings Panel.","Company has requested a hearing before the Panel, scheduled for June 2024."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-061330","json":"https://secwatch.observer/filing/0000950170-24-061330.json","markdown":"https://secwatch.observer/filing/0000950170-24-061330.md","text":"https://secwatch.observer/filing/0000950170-24-061330.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/811240/000095017024061330/0000950170-24-061330-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/811240/000095017024061330/biol-20240517.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T17:54:09.518114+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"c94dbbbb8a5efcf25a37ddeed8a6cf1b1d301348","claim":"BIOLASE, INC received a nasdaq deficiency notice notice regarding stockholders equity (rules 5550(b)).","evidence_excerpt":"May 14, 2024, BIOLASE, Inc. (the “Company”) received an additional staff determination letter from the Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC notifying the Company that because its Quarterly Report on Form 10-Q for the quarter ended March 31, 2024 that was filed with the U.S. Securities and Exchange Commission on May 13, 2024 reported stockholders’ equity of ($1,934,000) as of March 31, 2024, the Company does not comply with the minimum $2,500,000 stockholders’ equity requirement for continued listing set forth in Nasdaq Listing Rule 5550(b). As a result","evidence_source":"SEC 8-K Item 3.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/811240/000095017024061330/0000950170-24-061330-index.htm","confidence":0.9,"family_label":"Listing & Compliance Notices","details":[{"label":"Exchange","value":"nasdaq"},{"label":"Notice","value":"deficiency notice"},{"label":"Deficiency","value":"stockholders equity"},{"label":"Rules","value":"5550(b)"}],"fact_type":"exchange_compliance_notice"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}